Edition:
United States

Genetic Technologies Ltd (GENE.OQ)

GENE.OQ on NASDAQ Stock Exchange Capital Market

1.55USD
16 Feb 2018
Change (% chg)

$-0.04 (-2.52%)
Prev Close
$1.59
Open
$1.58
Day's High
$1.60
Day's Low
$1.49
Volume
49,243
Avg. Vol
88,025
52-wk High
$2.05
52-wk Low
$0.70

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Paul Kasian

2018 Non-Executive Chairman of the Board, Acting Chief Executive Officer

Kevin Fischer

2016 Chief Financial Officer, Company Secretary

Mark Ostrowski

50 2014 President of Phenogen Sciences Inc

Richard Allman

53 2012 Scientific Director

M. Luisa Ashdown

57 2012 Director of Global Licensing and Intellectual Property